Articles
Collaborative agreement to develop cancer therapies
Novogen has signed a collaborative agreement with the Ingham Institute to begin progressing its pipeline of cancer therapies. [ + ]
Imugene secures Japanese patent for Linguet
Imugene (ASX:IMU) will receive a Japanese patent that will allow it to explore developing products to treat bone loss using its Linguet drug delivery platform. [ + ]
Horsemeat and lab responsibilities
Crystal balls are needed if food analysts are to meet consumer expectations that all food adulteration scandals can be thwarted by laboratory testing. [ + ]
Mosaic software to manage new biological entity samples
Sample management software provider Titian Software has announced that Boehringer Ingelheim has implemented the company’s Mosaic sample management software for the inventory management, sample tracking and sample processing of new biological entities (NBE). [ + ]
Major medtech event to feature in Melbourne
The AusMedtech national medtech conference, now its sixth year, will for the first time be held in Melbourne in May. [ + ]
From additive fabrication to commercialisation
The Australian Institute for Innovative Materials, located at the University of Wollongong’s Innovation Campus, now includes a processing and devices facility to help bridge the gaps between research breakthroughs, prototyping and commercialisation. [ + ]
Industry comments on ANZTPA’s joint framework
AusBiotech has made a submission on behalf of the biotechnology industry to the Australia New Zealand Therapeutic Products Agency’s (ANZTPA) discussion paper. [ + ]
Bioengineered ears look and act like the real thing
Physicians at Weill Cornell Medical College and biomedical engineers at Cornell University have succeeded in building a facsimile of a living human ear that looks and acts like a natural ear. [ + ]
Ghost in the genome
It turns out genetics is not as complex as we thought. It’s even more complex. Associate Professor Kevin Morris has recently arrived from the US and is working on uncovering the startling complexity of gene regulation. [ + ]
AusBiotech commends Productivity Commission’s draft report on compulsory licensing of patents
AusBiotech has commended the “thorough work of commission and its December 2012 ‘Draft Report’ on Compulsory Licensing of Patents”. [ + ]
Patent review bonanza has industry under siege
Continual government reviews of the intellectual property system are creating uncertainty in the life sciences industry that could hurt its future success. [ + ]
Royal Mint achieves new level of trade effluent monitoring
The Royal Mint has selected Analytical Technology to equip its new effluent treatment plant. [ + ]
Industry leaders’ views needed in the 2013 AusBiotech Industry Position Survey
AusBiotech invites industry leaders to participate in the annual CEO Industry Position Survey 2013. [ + ]
Signal strength
Associate Professor Brendan Jenkins is helping to uncover the cellular signals involved in stomach cancer, which may one day be used as biomarkers or as new targets for treatment. [ + ]
Altered states
UWA’s Professor Ryan Lister’s research into the epigenome suggests the future clinical use of induced pluripotent stem cells should proceed with great caution. [ + ]
